Dr Webber has a long-standing interest in the regulation of stromal cell phenotype. He completed a PhD at the Institute of Nephrology, Cardiff University, in 2009. After this, he applied an understanding of TGF-beta signalling to the field of cancer by exploring the role of small extracellular vesicles (EVs), typically referred to as exosomes, in modulation of the tumour microenvironment.
In 2014 Dr Webber was the recipient of a prestigious Career Development Fellowship, funded by Prostate Cancer UK (2014 – 2020). This allowed him to begin exploring the translational use of EVs, principally as biomarkers for early detection of aggressive tumours (prostate and others). This experience was enhanced by additional training at the Erasmus MC, Rotterdam.
Dr Webber’s current research interests continue to focus on the role of EVs in tumour progression and development of EV-based biomarkers. Recent collaborations have allowed him to expand this research to include diseases such as breast cancer, mesothelioma and tuberous sclerosis complex. Dr Webber is a current board member of the UK Society for Extracellular Vesicles.
Dr Webber supervises a number of PGR students at both the MSc and PhD level, and actively contributes to teaching on a variety of programmes within the Swansea University Medical School.